![Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates, Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,](https://c8.alamy.com/comp/2CX4Y3N/teva-pharmaceutical-industries-new-ceo-jeremy-levin-speaks-during-a-news-conference-in-tel-aviv-may-9-2012-teva-pharmaceutical-industries-posted-a-40-percent-jump-in-quarterly-profit-that-beat-estimates-boosted-by-robust-sales-of-its-own-branded-products-and-generic-medicines-in-the-united-states-reutersnir-elias-israel-tags-business-health-2CX4Y3N.jpg)
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
![Teva Pharmaceuticals on Twitter: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay Teva Pharmaceuticals on Twitter: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay](https://pbs.twimg.com/media/EOU3ldBWAAAthk3.jpg)
Teva Pharmaceuticals on Twitter: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay
![Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | FiercePharma Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | FiercePharma](https://qtxasset.com/fiercepharma/1585082026/K%C3%A5re_Schultz.jpg/K%C3%A5re_Schultz.jpg?VersionId=Sip0eyB6sFNEjxw_3RP0JbV37_WsIdJ3)
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | FiercePharma
![Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation former CEO Mark Alles are sworn in prior to testifying by video conference during a hearing before the US Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation former CEO Mark Alles are sworn in prior to testifying by video conference during a hearing before the US](https://c8.alamy.com/comp/2CWY46Y/bristol-myers-squibb-ceo-giovanni-caforio-teva-pharmaceuticals-ceo-kare-schultz-and-celgene-corporation-former-ceo-mark-alles-are-sworn-in-prior-to-testifying-by-video-conference-during-a-hearing-before-the-us-house-of-representatives-committee-on-oversight-and-reform-focused-on-the-cost-of-prescription-drugs-in-the-us-capitol-in-washington-us-september-30-2020-greg-nashpool-via-reuters-2CWY46Y.jpg)
Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation former CEO Mark Alles are sworn in prior to testifying by video conference during a hearing before the US
![Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation former CEO Mark Alles are sworn in prior to testifying by video conference during a hearing before the US Bristol-Myers Squibb CEO Giovanni Caforio, Teva Pharmaceuticals CEO Kare Schultz, and Celgene Corporation former CEO Mark Alles are sworn in prior to testifying by video conference during a hearing before the US](https://c8.alamy.com/comp/2CWY3F9/bristol-myers-squibb-ceo-giovanni-caforio-teva-pharmaceuticals-ceo-kare-schultz-and-celgene-corporation-former-ceo-mark-alles-are-sworn-in-prior-to-testifying-by-video-conference-during-a-hearing-before-the-us-house-of-representatives-committee-on-oversight-and-reform-focused-on-the-cost-of-prescription-drugs-in-the-us-capitol-in-washington-us-september-30-2020-alex-edelmanpool-via-reuters-2CWY3F9.jpg)